Orphan drugs Reply

被引：0

作者：

Luzzatto, Lucio ^{[1
]}

Costa, Enrico ^{[2
]}

Schieppati, Arrigo ^{[3
]}

Remuzzi, Giuseppe ^{[4
,5
]}

机构：

[1] Muhimbili Univ Hlth & Allied Sci, Dar Es Salaal, Tanzania

[2] Azienda Osped Univ Integrata Verona, Dept Pharm, Verona, Italy

[3] Azienda Sociosanit Terr Papa Giovanni XXIII, Rare Dis Unit, Bergamo, Italy

[4] Ist Ric Farmacol Mario Negri IRCCS, I-24126 Bergamo, Italy

[5] Univ Milan, Dept Clin & Biomed Sci, Milan, Italy

来源：

关键词：

D O I：

10.1016/S0140-6736(19)30014-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1595 / 1596

页数：2

共 50 条

[21] Orphan drugs in Europe
Emma Dorey
Nature Biotechnology, 1999, 17 (8) : 737 - 737
[22] MONOPSONY OF ORPHAN DRUGS
Afify, Y.
VALUE IN HEALTH, 2017, 20 (05) : A69 - A69
[23] Drugs and orphan diseases
Blin, Olivier
Micallef, Joelle
THERAPIE, 2020, 75 (02): : 131 - 132
[24] ORPHAN DRUGS IN USA
HANESSE, B
TRECHOT, P
NETTER, P
ROYER, RJ
REVUE DE MEDECINE INTERNE, 1992, 13 (02): : 93 - 96
[25] Rescuing orphan drugs
Coombes, Rebecca
BMJ-BRITISH MEDICAL JOURNAL, 2023, 381
[26] DEVELOPMENTS IN ORPHAN DRUGS
CARTER, MJ
BENNETT, AR
FOOD AND DRUG LAW JOURNAL, 1989, 44 (06): : 627 - 632
[27] Pricing of orphan drugs
Leonard, J. V.
Richmond, S.
LANCET, 2009, 373 (9662) : 462 - 462
[28] Radiopharmaceuticals as orphan drugs
Swanson, DP
SEMINARS IN NUCLEAR MEDICINE, 1996, 26 (02) : 91 - 95
[29] Fostering Orphan Drugs
Haigney, Susan
Pharmaceutical Technology, 2022, 2022
[30] COMMENT ON ORPHAN DRUGS
MOON, SB
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1983, 17 (12): : 912 - 912